Jane Henderson

Ms. Jane P. Henderson is a Chief Financial Officer at Adagio Therapeutics, Inc., an Independent Non-Executive Director at Akero Therapeutics, Inc., an Independent Director at IVERIC bio, Inc., an Independent Director at Sesen Bio, Inc. and a Secretary & Treasurer at The EQUUS Foundation, Inc. She is on the Board of Directors at Akero Therapeutics, Inc., IVERIC bio, Inc. and Sesen Bio, Inc. Ms. Henderson was previously employed as a Chief Financial Officer by Turnstone Biologics, Inc., a Chief Financial Officer & Senior Vice President by Voyager Therapeutics, Inc., a Senior VP, Chief Financial & Business Officer by Kolltan Pharmaceuticals, Inc., a Vice President-Business Development by ISTA Pharmaceuticals, Inc., a CFO, Executive VP & Chief Business Officer by Axerion Therapeutics, Inc., a CFO, Secretary, Chief Business Officer & EVP by Panacos Pharmaceuticals, Inc., a Managing Director by CIBC World Markets Corp. (Old), a Senior Vice President by Lehman Brothers, Inc., a CFO & Head-Business Development by Axerion Pharmaceuticals, Inc., a Managing Director by Canadian Imperial Bank of Commerce, a Managing Director by HSBC Holdings Plc /US Auto Finance Business/, a Managing Director-Investment Banking Division by HSBC Securities (USA), Inc., and a Managing Director by Salomon Brothers. She received her undergraduate degree from Duke University.